Melbourne scientists have developed a potentially game-changing injectable alternative to blood thinners that could reduce the risk of internal bleeding, offering new hope for patients who rely on anticoagulant medications.
The breakthrough, developed by researchers based in Melbourne, centres on an injectable treatment designed to perform the clot-preventing role of conventional blood thinners while carrying a lower risk of the internal bleeding complications that can make those medications dangerous.
Internal bleeding is one of the most serious side effects associated with standard blood-thinning drugs, and a safer alternative could have significant implications for patients managing conditions that require ongoing anticoagulant therapy.
The development has been described as a potential game changer in the management of clotting-related health conditions.
